on Cynosure Lutronic
Cynosure Lutronic Expands Global Reach with Mosaic 3D™ Approval
Cynosure Lutronic has announced that its Mosaic 3D™ platform has achieved CE Mark approval under the European MDR, advancing its global expansion strategy. Mosaic 3D™, a non-ablative fractional laser system, is designed to enhance energy delivery while maintaining patient comfort and safety. Its approval signifies a vital milestone for the company.
The device features 3D Controlled Chaos Technology™ and an integrated cooling system, which optimize treatment outcomes and reduce patient discomfort. It has been lauded for its versatility in enhancing skin revitalization. Key opinion leaders such as Dr. Guy Erlich and Prof. Merete Haedersdal have validated its effectiveness in clinical settings.
Mosaic 3D™ will be featured prominently at the 2026 IMCAS World Congress, with a dedicated symposium to highlight its capabilities. The company remains consistent in pushing the boundaries of medical aesthetics by focusing on evidence-based innovation.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cynosure Lutronic news